Imprimis Pharmaceuticals Licenses IP
socalTECH
JUNE 17, 2013
San Diego-based Imprimis Pharmaceuticals said this morning that it has licensed a set of intellectual property assets, from Buderer Drug Company. Imprimis said it is developing innovations based on technology from the compounding pharmacy operations of Buderer. Financial details of the licensing deal were not announced.
Let's personalize your content